Use of Long-Acting Injectable Antipsychotics in Inpatients with Schizophrenia Spectrum Disorder in an Academic Psychiatric Hospital in Switzerland

Long-acting injectable antipsychotics (LAIs) offer many benefits to patients with schizophrenia spectrum disorder (SSD). They are used with very different frequencies due to questions of eligibility or patients and prescribers’ attitudes towards LAI use. We assessed the prescribing rates of LAIs in...

Descripción completa

Detalles Bibliográficos
Autores principales: Reymann, Stephan, Schoretsanitis, Georgios, Egger, Stephan T., Mohonko, Alexey, Kirschner, Matthias, Vetter, Stefan, Homan, Philipp, Seifritz, Erich, Burrer, Achim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955244/
https://www.ncbi.nlm.nih.gov/pubmed/35330441
http://dx.doi.org/10.3390/jpm12030441

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955244/
https://www.ncbi.nlm.nih.gov/pubmed/35330441
http://dx.doi.org/10.3390/jpm12030441

Ejemplares similares